RGNT

Regentis Biomaterials Ltd

• TipRanks·03/17 13:07

  Regentis Biomaterials develops and patents solvent-free manufacturing process

• Benzinga·03/17 12:35

  Regentis Biomaterials Develops New Manufacturing Process For GelrinC, Off-The-Shelf Hydrogel Synchronized Erosion And Resorbable Implant For Treatment Of Painful Injuries To Focal Articular Knee Cartilage

• TipRanks·03/02 11:39

  Regentis Biomaterials initiated with a Buy at ThinkEquity

• TipRanks·02/24 22:00

  Regentis Biomaterials Posts 2025 Results, Advances GelrinC Toward Phase III Milestones and 2026 EU Rollout

• Seeking Alpha·02/24 21:39

  Regentis Biomaterials Ltd. reports FY results

• TipRanks·02/19 13:57

  Regentis Biomaterials appoints Galit Reke as CMO

• TipRanks·02/17 14:57

  Regentis Biomaterials Expands European Clinical Network Ahead of 2026 GelrinC Launch

• TipRanks·02/17 13:45

  Regentis Biomaterials expands European clinical site network

• TipRanks·02/05 11:57

  Regentis Biomaterials Taps New CFO/Chief Business Officer as GelrinC Nears EU Launch and Midpoint of U.S. Phase III Trial

• TipRanks·02/04 14:01

  Regentis Biomaterials appoints Ori Gon as CFO, CBO

• Seeking Alpha·02/04 13:56

  Regentis Biomaterials appoints new CFO

• Benzinga·02/04 13:39

  Regentis Biomaterials Names Ori Gon Chief Financial Officer And Chief Business Officer, As GelrinC Progresses In US Food and Drug Administration Phase III Trial

• TipRanks·01/29 14:41

  Regentis Biomaterials Expands U.S. Phase III GelrinC Trial Network After Enrollment Surpasses Midpoint

• TipRanks·01/29 13:50

  Regentis Biomaterials expanding Phase III GelrinC clinical site network

• TipRanks·01/28 16:25

  Regentis Biomaterials Ltd trading resumes